Alx Oncology Holdings Inc

NASDAQ:ALXO   12:58:47 PM EDT
69.27
+1.40 (+2.06%)
Products

ALX Oncology Announces New Data From Aspen-01 Showing Promising Initial Clinical Responses In Patients With Advanced Solid Tumors

Published: 11/09/2020 14:14 GMT
(ALXO) - Alx Oncology Announces New Data From Aspen-01, the Phase 1b Study of Alx148, Showing Promising Initial Clinical Responses in Patients With Advanced Solid Tumors.
Alx Oncology Holdings Inc - Orr of 64% Observed in Patients With >2l Her2 Positive Gastric/gastroesophageal Junction Cancer.
Alx Oncology Holdings Inc - Orr of 75% and One Complete Response Observed in Patients With 1l Head and Neck Cancer.